Renee Brady, NC State, Forecasting Cancer: Predicting Individual Responses to Intermittent Androgen Deprivation Therapy in Prostate Cancer
Cox 306Intermittent androgen deprivation therapy (IADT) is an attractive treatment approach for biochemically recurrent prostate cancer (PCa), whereby cycling treatment on and off has been shown to limit toxicities and reduce cumulative dose. While IADT has been shown to delay the development of treatment resistance, underlying mechanisms and actionable biomarkers are required to accurately predict when…